Starting this spring, the Respiratory Syncytial Virus (RSV) vaccine will be available to adults aged 60 years and older residing in congregate living facilities, such as long-term care homes and ...

A new study utilizing next-generation sequencing reveals high RSV co-infection rates in hospitalized children, underscoring ...

An Australian-first study demonstrating the effectiveness of a new immunization against respiratory syncytial virus (RSV) for ...

Searches for NHS advice on norovirus topped one million this winter as NHS staff managed a quad-demic of viruses, according to new NHS data. There have been 1,021,436 visits to the norovirus advice in ...

Research from Stanley Manne Children's Research Institute at Ann & Robert H. Lurie Children's Hospital of Chicago strongly suggests that Kawasaki disease is caused by a single respiratory virus that ...

The Triad's three main healthcare systems separately announced Wednesday they will lift at 7 a.m. Thursday their respiratory ...

Vermont has the second lowest state fatality rate in the US (146.4 per 100K; Hawaii 112.8/100K). Mississippi (463.1/100K) and Oklahoma (459.1/100K) have the highest rates. The US average is 306.7/100K ...

The rollout of a vaccine for respiratory syncytial virus (RSV) has slashed hospital admissions by 30% among older people, ...

Population-based analyses of new vaccination programmes provide robust real-world evidence for post-licensure vaccine ...

New data from the Centers for Disease Control and Prevention suggest Georgia could see a rise in COVID-19 cases in the coming ...